BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) Stock Short Interest Report for October

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) was the recipient of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 5,430 shares, an increase of 99.4% from the October 15th total of 2,723 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 15,872 shares, the short-interest ratio is presently 0.3 days.

BioForce Nanosciences Trading Up 4.7%

BioForce Nanosciences stock traded up $0.31 during mid-day trading on Friday, hitting $6.97. The company’s stock had a trading volume of 4,485 shares, compared to its average volume of 6,697. BioForce Nanosciences has a twelve month low of $0.18 and a twelve month high of $10.99. The stock’s fifty day moving average price is $7.87 and its two-hundred day moving average price is $2.92.

BioForce Nanosciences (OTCMKTS:BFNH) last released its quarterly earnings data on Monday, November 9th. The company reported ($0.01) earnings per share for the quarter.

BioForce Nanosciences Company Profile

BioForce Nanosciences is a life-sciences technology company that has focused on applying nanotechnology to biological research and diagnostic applications. The company has been based in Ames, Iowa. Its products have included the Nano eNabler, an instrument for nanoscale deposition and patterning of biological materials, and the NanoBioProcessor platform for handling and analyzing small biological samples. BioForce has also developed the ViriChip platform, intended for detecting viruses and other biological targets.